4
Changes in Ownership
Immunome Inc. Filed Acc 0001104659-21-043486
Options or other derivatives
- Chief Development Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Giesing Dennis H · Chief Development Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-25 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +125,000 | $31.83 | 2031-03-24 | 125,000 | 125,000 | D |
Loading xslF345X03/tm2111257-2_4seq1.xml…